IP Library › Assignment 054202/0308
Patent Assignment
Reel/Frame 054202/0308

Assignment of Assignor's Interest

Recorded: 2020-10-28 Pages: 5
Assignor
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Property (1)
Treatment of Cancer Using a CD33 Chimeric Antigen Receptor
Application: 15/689,163 →
Publication: US 2018/0044423
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 28, 2020
From: RICHARDSON, CELESTE; SINGH, RESHMA
To: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
Reel/Frame 054202/0290 →
Assignment of Assignor's Interest Oct 28, 2020
From: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
To: NOVARTIS AG
Reel/Frame 054202/0298 →
Assignment of Assignor's Interest Oct 28, 2020
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 054202/0303 →
Assignment of Assignor's Interest Oct 28, 2020
From: NOVARTIS AG
To: NOVARTIS AG; THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 054202/0313 →
Assignment of Assignor's Interest Oct 30, 2020
From: EBERSBACH, HILMAR ERHARD; HUBER, THOMAS; JASCUR, JULIA
To: NOVARTIS PHARMA AG
Reel/Frame 054218/0631 →
Assignment of Assignor's Interest Oct 30, 2020
From: SONG, HUIJUAN; WU, QILONG; ZHANG, JIQUAN
To: CHINA NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH
Reel/Frame 054218/0642 →